# DOAC in Unusual Site Venous Thrombosis

> **NCT03778502** · — · COMPLETED · sponsor: **University of Malta** · enrollment: 358 (actual)

## Conditions studied

- Splanchnic Vein Thrombosis
- Cerebral Vein Thrombosis
- Ovarian Vein Thrombosis
- Renal Vein Thrombosis
- Retinal Vein Thrombosis

## Interventions

- **DRUG:** Direct Oral Anticoagulants

## Key facts

- **NCT ID:** NCT03778502
- **Lead sponsor:** University of Malta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778502, "DOAC in Unusual Site Venous Thrombosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03778502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*